Daily Archives: March 2, 2018


Tools in Action: ForwardFast branding for clinical trial program

            Last fall, we created a standardized brand identity and guidelines for clinical research and development communications for the HARMONEE Program from Adare Pharmaceuticals. Adare studies are underway with the goal of improving treatment for Eosinophilic esophagitis, including its novel orally disintegrating tablet (ODT) containing the active pharmaceutical ingredient fluticasone. Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease characterized by presence of tissue eosinophilia and symptoms of esophageal dysfunction. To date, no medications have been FDA-approved to treat this condition. The use of these identity guidelines will ensure that the elements, relevance, and benefits of […]